Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges

Area of Science:

• Otolaryngology
• Genetics
• Regenerative Medicine

Background:

• Hearing loss is the most common sensory deficit globally, with projections estimating 10% of the population affected by 2050.
• Genetic factors account for roughly half of congenital hearing loss cases.
• Current treatments like hearing aids and cochlear implants do not fully restore hearing.

Purpose of the Study:

• To review gene therapy strategies for hereditary hearing loss.
• To summarize recent preclinical advancements in genetic deafness research.
• To identify current obstacles for cochlear gene therapy.

Main Methods:

• Literature review of gene therapy strategies.
• Analysis of preclinical study outcomes in genetic hearing loss models.
• Identification and categorization of challenges in cochlear gene therapy.

Main Results:

• Gene therapy has shown promise in mouse models for certain forms of genetic deafness.
• Significant progress has been made in preclinical gene therapy research for hearing loss.
• Key challenges persist in translating these findings to human clinical applications.

Conclusions:

• Gene therapy is a rapidly advancing field for treating genetic hearing loss.
• Overcoming current obstacles is crucial for the future clinical success of cochlear gene therapy.
• Further research is needed to bridge the gap between preclinical promise and therapeutic reality.